Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

24 results
  1. ... and anxiety symptoms in dementia: the effects of ginkgo biloba extract EGb 761. Journal. ... L. Antihypertensive drugs decrease risk of Alzheimer disease: ginkgo ...
  2. ... Preuss UW, Wong JW, et al. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with ...
  3. ... 165. [ PubMed : 254898 ] ISRAEL1987 (Published Data Only) Israel L, Dell’Accio E, Martin G, Hugonot R. Ginkgo biloba extract and memory training programs. Comparative assessment on ...
  4. ... from another publication) [ PubMed : 23152282 ] Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with ginkgo biloba extract. A preliminary double-blind drug vs. placebo ...
  5. ... 2055. PMID: 18537221. [ PubMed : 18537221 ] [ CrossRef ] 224. Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer’s type. ...
  6. ... Salehi B, Imani R, Mohammadi MR, et al. Ginkgo biloba for ... T, et al. Long-term safety and efficacy of guanfacine extended release in children ...
  7. ... 110. Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine R. Influence of the severity of cognitive impairment on the effect in patients with mild to moderate Alzheimer’s disease: Multicentre of the Ginkgo biloba extract EGb 761 in Alzheimer’s disease. randomised controlled ...
  8. ... 58 J. I. Boullatta and A. M. Nace, “Safety Issues with Herbal Medicine,” Pharmacotherapy, 2000 20(3):257–269; S. Brent, H. Goldberg, A. Padula et al., “Spontaneous Bleeding Associated with Ginkgo Biloba,” Journal of General Internal Medicine, 2005 20:657– ...
  9. ... 20%) in the placebo group (p=0.02). Ginkgo Biloba . In one RCT comparing Ginkgo biloba plus risperidone with risperidone plus placebo, investigators found ...
  10. ... al. A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders. ... al. A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern- ...
previous · 1 · 2 · next